1 | handpiece to gently heat | | | | | | | 3 | 1.79% |
2 | a quick noninvasive nonablative | | | | | | | 3 | 1.79% |
3 | want to feel as | | | | | | | 3 | 1.79% |
4 | to feel as though | | | | | | | 3 | 1.79% |
5 | feel as though they’ve | | | | | | | 3 | 1.79% |
6 | as though they’ve lost | | | | | | | 3 | 1.79% |
7 | though they’ve lost control | | | | | | | 3 | 1.79% |
8 | they’ve lost control of | | | | | | | 3 | 1.79% |
9 | is a quick noninvasive | | | | | | | 3 | 1.79% |
10 | women don’t want to | | | | | | | 3 | 1.79% |
11 | thermiva® is a quick | | | | | | | 3 | 1.79% |
12 | body especially when it | | | | | | | 3 | 1.79% |
13 | especially when it affects | | | | | | | 3 | 1.79% |
14 | when it affects parts | | | | | | | 3 | 1.79% |
15 | it affects parts of | | | | | | | 3 | 1.79% |
16 | affects parts of their | | | | | | | 3 | 1.79% |
17 | don’t want to feel | | | | | | | 3 | 1.79% |
18 | quick noninvasive nonablative treatment | | | | | | | 3 | 1.79% |
19 | parts of their life | | | | | | | 3 | 1.79% |
20 | physiciancontrolled radiofrequency energy using | | | | | | | 3 | 1.79% |
21 | radiofrequency energy using a | | | | | | | 3 | 1.79% |
22 | energy using a thoughtfully | | | | | | | 3 | 1.79% |
23 | to gently heat tissue | | | | | | | 3 | 1.79% |
24 | noninvasive nonablative treatment delivering | | | | | | | 3 | 1.79% |
25 | designed handpiece to gently | | | | | | | 3 | 1.79% |
26 | they’ve lost control of their | | | | | | | 2 | 1.19% |
27 | a fever or skin infection | | | | | | | 1 | 0.60% |
28 | have a fever or skin | | | | | | | 1 | 0.60% |
29 | pregnant have a fever or | | | | | | | 1 | 0.60% |
30 | on patients who are | | | | | | | 1 | 0.60% |
31 | should not be used | | | | | | | 1 | 0.60% |
32 | used on patients who | | | | | | | 1 | 0.60% |
33 | thermicom terms | | | | | | | 1 | 0.60% |
34 | terms of | | | | | | | 1 | 0.60% |
35 | terms of use | | | | | | | 1 | 0.60% |
36 | not be used on | | | | | | | 1 | 0.60% |
37 | be used on patients | | | | | | | 1 | 0.60% |
38 | temperature controlled rf system | | | | | | | 1 | 0.60% |
39 | products should not be | | | | | | | 1 | 0.60% |
40 | use in dermatological and | | | | | | | 1 | 0.60% |